EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Meta‐analysis: The efficacy of therapeutic drug monitoring of anti‐ TNF ‐therapy in inflammatory bowel disease

Sonika Sethi iD, Shiluka Dias, Aditi Kumar iD, Jonathan Blackwell iD, Matthew J Brookes, Jonathan P Segal iD

Alimentary Pharmacology & Therapeutics · 2023-06 · 57 (12) · 1362-1374

DOI: 10.1111/apt.17313 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 09.12.2022. Verfasst von Sonika Sethi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sandwell and West Birmingham NHS Trust, West Midlands, West Bromwich, UK. Hauptthemen laut MEDLINE: Drug Monitoring, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims This systematic review and meta‐analysis aimed to determine whether the use of therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) patients on anti‐tumour necrosis factor (anti‐TNF) therapy results in improved rates of clinical and endoscopic remission, surgery, corticosteroid‐free remission and hospitalisation.

Methods

MEDLINE, EMBASE, EMBASE classic, PubMed, Cochrane central databases register of controlled trials and Cochrane Specialised Trials Register were searched between 01 Janurary 1946 and 08 April 2022. Randomised controlled trials (RCTs) and prospective and retrospective observational studies were included, comparing TDM to standard of care (SOC) or reactive vs proactive TDM. Results were reported as pooled relative risks (RR) with 95% confidence intervals (95% CI).

Results

Twenty‐six studies, including 9 RCTs, were included. Compared to SOC, proactive TDM was associated with a significantly decreased risk of treatment failure (RR 0.64, 95% CI 0.48–0.85 p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringInflammatory Bowel DiseasesHumansTreatment FailureRetrospective Studies

Stichwörter der Autor:innen

IBDTDMbiologicsmeta-analysistherapeutic drug monitoring

Autor:innen und Institutionen

  • Department of Gastroenterology, Sandwell and West Birmingham NHS Trust, West Midlands, West Bromwich, UK.
  • Department of Gastroenterology, Guys and St Thomas' NHS Trust, London, UK.
  • Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Department of Gastroenterology, Croydon Healthcare NHS Trust, London, UK.
  • Research Institute in Healthcare Sciences, University of Wolverhampton, Wolverhampton, UK.
  • Department of Medicine, University of Melbourne, Melbourne, Australia.

ORCID-Profile: Sonika Sethi, Aditi Kumar, Jonathan Blackwell, Jonathan P Segal

Zitieren

APA

Sethi, S., Dias, S., Kumar, A., Blackwell, J., Brookes, M. J., & Segal, J. P. (2023). Meta‐analysis: The efficacy of therapeutic drug monitoring of anti‐ TNF ‐therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 57(12), 1362-1374. https://doi.org/10.1111/apt.17313

Vancouver

Sethi S, Dias S, Kumar A, Blackwell J, Brookes MJ, Segal JP. Meta‐analysis: The efficacy of therapeutic drug monitoring of anti‐ TNF ‐therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2023;57(12):1362-1374. doi:10.1111/apt.17313

BibTeX
@article{Sethi2023,
  author = {Sethi, Sonika and Dias, Shiluka and Kumar, Aditi and Blackwell, Jonathan and Brookes, Matthew J and Segal, Jonathan P},
  title = {Meta‐analysis: The efficacy of therapeutic drug monitoring of anti‐ TNF ‐therapy in inflammatory bowel disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  volume = {57},
  number = {12},
  pages = {1362--1374},
  doi = {10.1111/apt.17313}
}
Kostenlos starten →